Associate Director, Market Access and HTA, UK and Ireland
Revolution Medicines is a global, commercial-state oncology company dedicated to discovering, developing and delivering innovative medicines for patients with RAS-addicted cancers. Leveraging its differentiated RAS(ON) tri-complex inhibitor platform, the company is advancing a broad, integrated portfolio of oral RAS(ON) inhibitors designed to directly target the active, cancer-driving state of RAS. Founded on rigorous scientific inquiry and a willingness to challenge long-held assumptions, Revolution Medicines is committed to changing the trajectory of disease for patients with RAS-addicted cancers worldwide.
Our people are united by a shared way of working: follow the science, challenge assumptions, act with urgency and hold ourselves to a high standard of rigor—all in service of patients.
The Opportunity:
The Associate Director, Market Access and HTA, is responsible for leading end-to-end reimbursement activities to ensure timely, sustainable patient access to innovative oncology therapies. Working closely with the Senior Director, Market Access, this role involves delivering high-quality HTA submissions (NICE, SMC, NCPE), supporting the development of Market Access strategies, core pricing and access deliverables, and guiding evidence generation to support value propositions.
The incumbent will part
